Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-015731

SVP, Business Development sold 12,529 shares at an average $19.96 ($250,092)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Birznieks Gunther SVP, Business Development 2019-03-01 Sale −3,741 $20.14 $75,325 160,039 D: show line 1 in the form
Birznieks Gunther SVP, Business Development 2019-03-04 Sale −8,788 $19.89 $174,767 151,251 D: show line 2 in the form
Open-market sales · 12,529 sh · avg $19.96 · $250,092
Loading xslF345X03/doc4.xml…